Submissions are open for the upcoming issue.

Molecular Medicine Peer-reviewed scientific journal

Found: 8

ОРИГИНАЛЬНОЕ ИССЛЕДОВАНИЕ2021

PHASE I CLINICAL STUDY OF A NEW RADIOPHARMACEUTICAL BASED ON RECOMBINANT TARGET MOLECULES DARPIN9_29 LABELED WITH 99mTECHNETIUM FOR RADIONUCLIDE DIAGNOSIS OF THE Her2/neu-POSITIVE BREAST CANCER

Introduction. The main attention of researchers is paid to the study of one of the members of the EGF family – the receptor of epidermal growth factor 2 (Her2/neu), the overexpression of which is detected in 15–20% of cases of invasive breast cancer and had an…

10.29296/24999490-2021-02-06Details ↗
ОРИГИНАЛЬНОЕ ИССЛЕДОВАНИЕ2021

SINGLE-PHOTON EMISSION COMPUTERIZED TOMOGRAPHY WITH 99mTc-DARPin9_29 IN DIAGNOSTICS OF BREAST CANCER WITH Her2/neu OVEREXPRESSION: FIRST CLINICAL EXPЕRIENCE

Introduction. In recent years, alternative framework proteins are used for the targeted radionuclide imaging. Molecules of DARPin (Design Ankyrin Repeat Protein) are one of the representatives of scaffolds. Despite the continued increase in the number of molec…

10.29296/24999490-2021-01-06Details ↗
ОРИГИНАЛЬНОЕ ИССЛЕДОВАНИЕ2020

MOLECULAR GENETIC CHARACTERISTICS OF NON-SMALL CELL LUNG CANCER USING MULTI-TARGET SINGLE-BASE ELONGATION AND FRAGMENT ANALYSIS

Background. Lung cancer is the most frequent cause of cancer mortality. The prevailing type is non-small cell lung cancer (NSCLC), in the treatment of which EGFR tyrosine kinase inhibitors are actively used, as well as a combination of BRAF and MEK inhibitors.…

10.29296/24999490-2020-03-06Details ↗
ОРИГИНАЛЬНОЕ ИССЛЕДОВАНИЕ2018

INVESTIGATIONS OF THE 125I-LABELLED TARGET MOLECULES DARPIN9_29 FOR RADIONUCLIDE DIAGNOSTICS OF MALIGNANT TUMORS WITH HER2/NEU OVEREXPRESSION

Introduction. Her2/neu is one of the most studied molecular target the overexpression of which is associated with poor prognosis and aggressive course of the disease. The use of modern non-invasive radionuclide techniques with the application of highly affinit…

10.29296/24999490-2018-06-07Details ↗
ОРИГИНАЛЬНОЕ ИССЛЕДОВАНИЕ2015

ACTUAL ASPECTS OF MOLECULAR-BIOLOGY CLASSIFICATION OF BREAST CANCER

There is represented immunohistochemical and molecular biological characteristic of some histological types of breast cancer. The assessment of molecular biomarkers in breast cancer has two practical results: identification of risk groups, requiring additional…

Details ↗
ОРИГИНАЛЬНОЕ ИССЛЕДОВАНИЕ2015

CLINICAL SIGNIFICANCE OF BIOLOGICAL OPTIONS OF BREAST CANCER

Breast cancer (BC) occupies the first place in morbidity and mortality rate in females in developed counties. From the point of view of biology BC proves to be the heterogenic disease, caused by genetic variability. It determines the phenotype of tumor and sen…

Details ↗
Research article2014

MOLECULAR GENETIC MARKERS OF NON-SMALL CELL LUNG CANCER

Lung cancer is one of the most common oncologic diseases in the world and the most frequent cause of the death from malignant neoplasms. Last decade’s studies revealed significant number of molecular events leading to the onset and development of non-small cel…

Details ↗
Research article2014

INCULIN-LIKE GROWTH FACTORS IN THE SERUM OF BREAST CANCER PATIENTS

Introduction. Breast cancer pathogenesis is associated with alterations in processes of regulating of IGF effects and also in IGF-signaling pathway activation. The direct correlation between high IGF blood serum levels and the rescue of malignancies in prostat…

Details ↗

Article search and quick navigation

Navigation